This year’s Symposium, “Mechanistic Insights into Emerging Therapeutic Platforms,” is an exciting program chaired by Anthony Oro

Travel Award is available for an ESDR Member!

Send your abstract now! The deadline is 1 August 2025

Website

Chaired by Anthony Oro, MD, PhD, Eugene and Gloria Bauer Professor at Stanford Medicine, the 2025 Montagna Symposium will focus on emerging paradigms in personalized medicine. Population studies have raised questions about why individuals do not respond to established therapies. Patients are individuals with personalized social, behavioral, and genetic determinants, but knowledge gaps exist regarding how these determinants influence diagnosis and treatment of cutaneous diseases. The goal of this Symposium is to highlight emerging avenues of investigation and streamline their incorporation into clinical medicine for our patients. Program Co-Chairs are Masa Amagai, MD, PhD, Professor and Chair, Department of Dermatology, Keio University School of Medicine and Vice President for Research, Keio University, and Aimee Payne, MD, PhD, Herbert and Florence Irving Professor and Chair of Dermatology at Columbia University Irving Medical Center.

Montagna Symposium

Mechanistic Insights into Emerging Therapeutic Platforms
Oct. 16-20, 2025
Location: Salishan Lodge, Gleneden Beach, Oregon

We are at an unprecedented nexus in medical research with the rise of distinct therapeutic platforms that promise definitive therapies for previously chronic or incurable diseases. Because of its accessibility, the skin has traditionally provided mechanistic insights that underpin the platform, and a proving ground for the early human studies.

At the 72nd annual Montagna Symposium, participants will learn about the basic science underpinnings for exciting emerging small molecule, antibody, RNA, and cell and gene therapeutics, early successes of the platform and their targets, and gaps in knowledge where additional investigation will lead to improved and long-lasting definitive therapies.

Symposium Objectives:

  1. Further the attendees’ understanding of the mechanistic basis of tissue regeneration therapies and the current patient responses.
  2. Elucidate the mechanistic basis of precision immune therapies and the current patient responses
  3. Explore the mechanistic basis of novel immunomodulatory therapies and the current patient responses.
  4. Gain a better understanding of the mechanistic basis of RNA medicines and the current patient responses
  5. Explore the mechanistic basis of novel cancer therapeutics and the current patient responses, generating dialogue to bridge these gaps and inspire research directions.
  6. Facilitate networking activities as a catalyst for future collaborative research endeavors and relationships

 

Abstracts:

A limited number of posters selected from submitted abstracts will be accepted for presentation at the meeting, and submissions for short oral presentations will be selected from abstracts to create the final program of meeting speakers. Please apply on our website: https://montagnasymposium.org/travel-awards/

Important Dates:

  • August 1: Abstract Submission Deadline
  • August 31: Early Bird Registration Ends (Discounted Price)
  • October 15: Registration Closes